Company
Weave Bio
Drug development is knowledge orchestration
- Status
- Operatingas of 2026-09-22
- Business model
- B2B
- Headquarters
- San Francisco, California, United States
- Customers
- For biotech, pharma, and CRO teams
- Legal name
- Weave Platform, Inc.
- weave.bio (opens in a new tab)
- LinkedIn (opens in a new tab)
- X (opens in a new tab)
- Careers (opens in a new tab)
Claim, correct or request removal
Record updated 28 September 2026
About
Weave is an AI-native platform for drug development teams where source data, submission content, and programs decisions stay connected.
Funding snapshot
- Total raised
- $13MSEC form D sum, as of 2026-09-28Source (opens in a new tab)
- Latest round
- Round, $11.4M2023-12-08
Funding rounds
- Round, 2023
- $11.4M2023-12-08, SEC form D sold, 10 investors
- Round, 2022
- $1.6M2022-08-07, SEC form D sold, 15 investors
Products
- Web
- Weave Platform
Loading relationship preview